The studio confirmed his departure in a statement, attributing it to “creative differences.” Derrickson, who oversaw the first “Doctor Strange,” will remain as an executive producer.
“Marvel Studios and Scott Derrickson have amicably parted ways on ‘Doctor Strange in the Multiverse of Madness’ due to creative differences,” Marvel said in a statement to Variety. “We remain grateful to Scott for his contributions to the MCU.”
Derrickson also said the decision was mutual.
“Marvel and I have mutually agreed to part ways on ‘Doctor Strange: In the Multiverse of Madness’ due to creative differences,” Derrickson tweeted. “I am thankful for our collaboration and will remain on as EP.”
Marvel and I have mutually agreed to part ways on Doctor Strange: In the Multiverse of Madness due to creative differences. I am thankful for our collaboration and will remain on as EP.
— N O S ⋊ Ɔ I ᴚ ᴚ Ǝ ᗡ ⊥ ⊥ O Ɔ S (@scottderrickson) January 10, 2020
The film will begin production in May and there are not expected to be any delays when it comes to shooting. The search for a replacement is currently underway.
“Doctor Strange” was a critical and commercial success when it opened in 2016, grossing nearly $680 million globally. The sequel will find Benedict Cumberbatch returning as Strange, a master of mystic arts. Elizabeth Olsen, who plays Scarlet Witch, is also expected to appear in the film.
“Doctor Strange in the Multiverse of Madness” is scheduled for release on May 7, 2021. Derrickson’s credits include “The Exorcism of Emily Rose” and “Sinister.” Marvel has several films slated to hit theaters before Doctor Strange conjures up his return to the big screen. This May brings “Black Widow,” with Scarlett Johansson reprising her role as the former Soviet spy, and 2020 will close out with the November release of “The Eternals,” the story of a race of immortal aliens. In February 2021, Marvel will unveil “Shang-Chi and the Legend of the Ten Rings,” its first Asian-led film.